Navigation Links
OTC Markets Group Congratulates Immune Pharmaceuticals on NASDAQ Listing
Date:8/21/2014

NEW YORK, Aug. 21, 2014 /PRNewswire/ -- OTC Markets Group Inc. (OTCQX: OTCM) congratulates Immune Pharmaceuticals Inc., a biotechnology company, on its approval to list on The NASDAQ Capital Market.  Immune previously traded on OTCQX®, the best marketplace for established U.S. and global companies operated by OTC Markets Group.

Logo - http://photos.prnewswire.com/prnh/20110118/MM31963LOGO

"We congratulate Immune Pharmaceuticals on the successful execution of its growth strategy and achievement of this important milestone," said R. Cromwell Coulson, President and CEO of OTC Markets Group.  "OTCQX has provided its investors with an efficient, transparent and information-rich trading market so they can easily analyze, value and trade its securities.  We are proud to have helped contribute to Immune's success as a public company as it takes this next step."     

"Immune Pharma went public one year ago and started trading on OTCQX.  Over the past six months, we have significantly increased our daily trading volume and raised capital to prepare for execution on our clinical milestones and for up-listing.  On Thursday, August 21, 2014, we will begin trading on The Nasdaq Capital Market, enabling additional investors to participate in our story," said Dr. Daniel Teper, CEO of Immune.

OTCQX is the marketplace of choice for U.S. and global companies that are looking to execute their business plans and graduate to a U.S. stock exchange listing.  Immune is the sixth OTCQX company to graduate to the NYSE MKT or NASDAQ markets this year.  Others include: BioPath Holdings Inc., Cellectar Biosciences Inc., Gulf Coast Ultra Deep Loyalty Trust, RXI Pharmaceuticals Corp. and Sphere 3D Corp.

About OTC Markets Group Inc.
OTC Markets Group Inc. (OTCQX: OTCM) operates Open, Transparent and Connected financial marketplaces for 10,000 U.S. and global securities.  Through our OTC Link® ATS, we directly link a diverse network of broker-dealers that provide liquidity and execution services for a wide spectrum of securities.  We organize these securities into marketplaces to better inform investors of opportunities and risks – OTCQX®, The Best Marketplace; OTCQB®, The Venture Marketplace; and OTC Pink®, The Open Marketplace.  Our data-driven platform enables investors to easily trade through the broker of their choice at the best possible price and empowers a broad range of companies to improve the quality and availability of information for their investors.  To learn more about how we create better informed and more efficient financial marketplaces, visit www.otcmarkets.com.

OTC Link ATS is operated by OTC Link LLC, member FINRA/SIPC and SEC regulated ATS.

Subscribe to the OTC Markets RSS Feed


'/>"/>
SOURCE OTC Markets Group Inc.
Copyright©2014 PR Newswire.
All rights reserved

Related biology technology :

1. Molecular Diagnostics Markets
2. Microarray Markets - 2013 Report Examines Companies that are Actively Developing and Marketing Microarray Instrumentation or Microarray Biochips
3. Stem Cell Markets - 2013 Report Examines the Use of Stem Cells in Developing New Therapies for Disease
4. BCC Research Publishes a New Report On Global Markets for Flow Cytometry
5. Globalizing Clinical Trials to Include Emerging Markets, New Life Science Webinar Hosted by Xtalks
6. BCC Research Publishes a New Report on Global Markets for Biochips
7. BCC Research Publishes a New Report On Global Markets for Rnai Technologies
8. Interventional Cardiology Devices - Emerging Markets 2009-2015
9. IDC MarketScape annovera la soluzione cloud-based di Veeva tra le principali soluzioni CRM dedicate alle scienze della vita
10. IDC MarketScape Named Cloud-based Veeva a Leader in Life Sciences CRM
11. Point of Care Diagnostic Testing: World Markets Report 2013
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:5/24/2017)... ... May 24, 2017 , ... ... as treasurer for the Mid-Atlantic chapter of the Healthcare Businesswomen’s Association ... , The HBA Mid-Atlantic chapter board meets in person once each quarter and ...
(Date:5/24/2017)... (PRWEB) , ... May 24, 2017 , ... ... systems are increasingly being developed with Wi-Fi connectivity to reduce the amount of ... room to room. In addition, compact mobile devices including infusion pumps, heart and ...
(Date:5/23/2017)... ... May 23, 2017 , ... ... source of human cardiovascular cells for research and the development of cardiac ... possible to generate large numbers of cardiomyocytes (hPSC-CMs). Due to varying differentiation ...
(Date:5/23/2017)... ... , ... Vortex Biosciences , provider of circulating tumor cell (CTC) capture ... using Vortex microfluidic technology ” in Nature Precision Oncology on May 8th. The ... and Dr. Matthew Rettig at the University of California, Los Angeles. The publication describes ...
Breaking Biology Technology:
(Date:5/16/2017)... 2017  Veratad Technologies, LLC ( www.veratad.com ), an ... identity verification solutions, announced today they will participate as ... 15 thru May 17, 2017, in Washington ... Center. Identity impacts the lives of ... quickly evolving digital world, defining identity is critical to ...
(Date:4/19/2017)... York , April 19, 2017 ... as its vendor landscape is marked by the presence ... market is however held by five major players - ... Together these companies accounted for nearly 61% of the ... the leading companies in the global military biometrics market ...
(Date:4/13/2017)... 2017 According to a new market research report ... Identity Administration, and Authorization), Service, Authentication Type, Deployment Mode, Vertical, and Region ... expected to grow from USD 14.30 Billion in 2017 to USD 31.75 ... ... MarketsandMarkets Logo ...
Breaking Biology News(10 mins):